Your session is about to expire
← Back to Search
Smart Technology for COVID-19 Disability in Older Adults
N/A
Waitlist Available
Led By Rachel M Proffitt, OTD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have difficulty with at least 1 self-care task or 2 daily living tasks
Over the age of 65
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial aims to help reduce disability and improve quality of life for rural, older adults with disabilities, by providing a smart sensor system to help them stay connected to their community.
Who is the study for?
This trial is for older adults over 65 living in rural areas with internet access, who have trouble with daily self-care or living tasks but can stand (with help if needed). They shouldn't plan to move soon, live in care facilities, have severe cognitive issues, be frequently hospitalized, receive home therapy/nursing, or have a short life expectancy.Check my eligibility
What is being tested?
The study tests whether smart technology can help reduce disabilities and improve the quality of life for these older adults. It involves using a smart sensor system versus standard health education to see if there's an improvement in managing their own health.See study design
What are the potential side effects?
Since this trial focuses on smart technology and education rather than medication, traditional side effects are not expected. However, participants may experience frustration or difficulty using new technologies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I struggle with at least one personal care task or two everyday tasks.
Select...
I am over 65 years old.
Select...
I can stand up with or without help.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Katz ADL Index
Change in PROMIS-29
Secondary outcome measures
Change in Canadian Occupational Performance Measure
Change in Hospital Anxiety and Depression Scale
Change in Patient Activation Measure
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Self ManagementExperimental Treatment1 Intervention
The 5A's Behavior Change Mode [39] is the framework for the self-management intervention. The five "A"s will be addressed through the integration of the self-management intervention and the sensor system. There will be a minimum of four intervention sessions with each healthcare profession (OT, RN, and SW) for 12 visits per participant.
Group II: Health EducationActive Control1 Intervention
Participant's randomized to the standard health education arm will receive the intervention at Month 1 and then months 3, 6, 9 and 12.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Self Management
2005
N/A
~380
Find a Location
Who is running the clinical trial?
University of Missouri-ColumbiaLead Sponsor
361 Previous Clinical Trials
627,936 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,006 Total Patients Enrolled
Rachel M Proffitt, OTDPrincipal InvestigatorUniversity of Missouri-Columbia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently receiving physical, occupational therapy, or nursing care at home.I struggle with at least one personal care task or two everyday tasks.I am over 65 years old.I am fully independent in daily activities.I can stand up with or without help.
Research Study Groups:
This trial has the following groups:- Group 1: Self Management
- Group 2: Health Education
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals are being enrolled in this clinical experiment?
"Affirmative. According to the information displayed on clinicaltrials.gov, this medical trial is actively seeking out volunteers and was first posted on June 1st 2022 before being updated most recently on July 22nd 2022 with a total of 64 individuals needed from one site."
Answered by AI
Is recruitment still open for this trial?
"Correct. The clinicaltrials.gov website states that this research is actively seeking participants, with the initial listing taking place on June 1st 2022 and an update posted as recently as July 22nd 2022. 64 individuals are needed to be recruited from 1 medical centre."
Answered by AI
What is the primary aim of this scientific inquiry?
"This one year trial has been designed to measure the Change in PROMIS-29, with secondary objectives of evaluating Technology Experience Profile (Experience with technology), Change in Patient Activation Measure (Patient activation/self-efficacy) and Change in Hospital Anxiety and Depression Scale (Depression and anxiety)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger